Cardiac AI Monitoring and Diagnostics Market Analysis, Trends, Growth and Future Challenges
Cardiac AI Monitoring and Diagnostics Market Growth, Size, Trends Analysis - By Product, By Type, By Application, By End-User - Regional Outlook, Competitive Strategies and Segment Forecast to 2034
| Published: May-2025 | Report ID: HLCA25146 | Pages: 1 - 250 | Formats*: |
| Category : Healthcare | |||
Cardiac AI Monitoring and Diagnostics Introduction and Overview
According to SPER Market Research, the Global Cardiac AI Monitoring and Diagnostics Market is estimated to reach USD 13780.98 million by 2034 with a CAGR of 27.11%.
The report includes an in-depth analysis of the Global Cardiac AI Monitoring and Diagnostics Market, including market size and trends, product mix, Applications, and supplier analysis. The cardiac AI monitoring and diagnostics market is anticipated to reach a value of USD 1251.65 million in 2024 and expand at a compound yearly growth rate (CAGR) of over 27.11% between 2025 and 2034. An important factor driving the market is the increasing technological developments in cardiac AI monitoring and diagnostics. Furthermore, the market is being encouraged by the expanding emphasis on precision medicine, the rising frequency of cardiovascular illnesses, and the growing need for remote monitoring solutions.
By Product Insights
The market is divided into three segments based on product: services, software solutions, and hardware. In 2024, the market was dominated by the hardware sector. By making it easier to execute computation-intensive algorithms, hardware innovations, especially in graphics processing units (GPUs) and tensor processing units (TPUs), are essential for improving cardiac AI monitoring and diagnostics. These sophisticated processors speed up diagnostic insights and decision-making processes by enabling real-time processing of cardiac data thanks to their greatly increased computational power.
By Type Insights
Based on type, the cardiac AI monitoring and diagnostics market is divided into cardiac diagnostics and cardiac monitoring. The cardiac diagnostics segment includes imaging, ECG-based, and other diagnostic techniques, which accounted for the largest revenue share in 2024. AI algorithms can find patterns in cardiac data, allowing early detection of diseases. This helps in timely treatment and prevents serious complications.
By Application Insights
The market for cardiac AI monitoring and diagnostics is segmented by application, including ischaemic heart disease, stenosis, cardiac arrhythmias, and stroke. In 2024, the cardiac arrhythmias segment led the market. AI algorithms can examine continuous electrocardiogram (ECG) recordings to spot small changes in heart rhythm that signal arrhythmias. These systems help identify arrhythmias early, allowing for prompt treatment. AI-based detection algorithms can accurately distinguish between various arrhythmias, improving diagnosis and patient management by reducing false positives and negatives.
Regional Insights
North America's cardiac AI monitoring and diagnostics market had the largest revenue share in 2024 and is expected to grow significantly. The region is a leader in healthcare technology, with many companies and research institutions creating AI solutions for cardiac care. It is home to esteemed medical institutions and experts in cardiovascular medicine. Their knowledge, along with AI integration, contributes to high-quality care, accurate diagnostics, and personalized treatment, driving market growth in North America.
Market Competitive Landscape
The market leaders in cardiac AI monitoring and diagnostics are concentrating on creating cutting-edge products and broadening their geographic reach in order to meet the rising demand for these services.
Additionally, they are establishing strategic alliances and partnerships to improve their capacities and obtain a competitive advantage. In order to introduce cutting-edge technologies and enhance the precision and effectiveness of their products, major players in the cardiac AI monitoring and diagnostics market are making significant investments in research and development.
Recent Developments:
- January 2024: Cleerly, a company that develops a new standard of care for heart disease diagnosis, announced the release of the Cleerly ISCHAEMIA, an automated machine learning-based decision support tool used to diagnose patients undergoing coronary computed tomography angiography (CCTA) analysis with Cleerly LABS software.
- In May 2023, Volta Medical, a health tech company that creates AI tools for electrophysiologists, announced that the FDA approved Volta AF-Xplorer, an AI companion for assessing complex AF and atrial tachycardia procedures.
- In May 2023, the AI intelligence firm Philips DiA Imaging Analysis was acquired by Koninklijke Philips N.V. The acquisition would improve the company's standing in the market for cardiac AI monitoring and diagnostics.
- Aidoc. introduced its cardiovascular AI solutions package in March 2023. Aidoc's cardiovascular solutions aggregate data mechanically and use AI algorithms to generate clinical insights for more effective cardiac diagnostics.
Scope of the report:
| Report Metric | Details |
| Market size available for years | 2021-2034 |
| Base year considered | 2024 |
| Forecast period | 2025-2034 |
| Segments covered | By Product, By Type, By Application, By End-User |
| Regions covered | North America, Latin America, Asia-Pacific, Europe, and Middle East & Africa |
| Companies Covered | CardiAI, Cleerly, Inc, DiA Imaging Analysis, HeartVista Inc, IDOVEN, Koninklijke Philips N.V, RSIP Vision, Tempus, Ultrasight, Ultromics Limited. |
- Global Cardiac AI Monitoring and Diagnostics Market Size (FY’2021-FY’2034)
- Overview of Global Cardiac AI Monitoring and Diagnostics Market
- Segmentation of Global Cardiac AI Monitoring and Diagnostics Market By Product (Hardware, Software Solutions, Services)
- Segmentation of Global Cardiac AI Monitoring and Diagnostics Market By Type (Cardiac Diagnostics, Cardiac Monitoring)
- Segmentation of Global Cardiac AI Monitoring and Diagnostics Market By Application (Cardiac Arrhythmias, Stroke, Ischemic Heart Disease, Stenosis)
- Segmentation of Global Cardiac AI Monitoring and Diagnostics Market By End-User (Hospitals, Specialty clinics, Diagnostic centers, Research and academic institutes, Other end-users)
- Statistical Snap of Global Cardiac AI Monitoring and Diagnostics Gel Market
- Expansion Analysis of Global Cardiac AI Monitoring and Diagnostics Market
- Problems and Obstacles in Global Cardiac AI Monitoring and Diagnostics Market
- Competitive Landscape in the Global Cardiac AI Monitoring and Diagnostics Market
- Details on Current Investment in Global Cardiac AI Monitoring and Diagnostics Market
- Competitive Analysis of Global Cardiac AI Monitoring and Diagnostics Market
- Prominent Players in the Global Cardiac AI Monitoring and Diagnostics Market
- SWOT Analysis of Global Cardiac AI Monitoring and Diagnostics Market
- Global Cardiac AI Monitoring and Diagnostics Market Future Outlook and Projections (FY’2025-FY’2034)
- Recommendations from Analyst
1. Introduction
- 1.1.Scope of the report
- 1.2.Market segment analysis
2. Research Methodology
- 2.1.Research data source
- 2.1.1.Secondary Data
- 2.1.2.Primary Data
- 2.1.3.SPER’s internal database
- 2.1.4.Premium insight from KOL’s
- 2.2.Market size estimation
- 2.2.1.Top-down and Bottom-up approach
- 2.3.Data triangulation
3. Executive Summary
4.Market Dynamics
- 4.1.Driver, Restraint, Opportunity and Challenges analysis
- 4.1.1.Drivers
- 4.1.2.Restraints
- 4.1.3.Opportunities
- 4.1.4.Challenges
5. Market variable and outlook
- 5.1.SWOT Analysis
- 5.1.1.Strengths
- 5.1.2.Weaknesses
- 5.1.3.Opportunities
- 5.1.4.Threats
- 5.2.PESTEL Analysis
- 5.2.1.Political Landscape
- 5.2.2.Economic Landscape
- 5.2.3.Social Landscape
- 5.2.4.Technological Landscape
- 5.2.5.Environmental Landscape
- 5.2.6.Legal Landscape
- 5.3. PORTER’s Five Forces
- 5.3.1.Bargaining power of suppliers
- 5.3.2.Bargaining power of buyers
- 5.3.3.Threat of Substitute
- 5.3.4.Threat of new entrant
- 5.3.5.Competitive rivalry
- 5.4.Heat Map Analysis
6. Competitive Landscape
- 6.1.Global Cardiac AI Monitoring and Diagnostics Market Manufacturing Base Distribution, Sales Area, Product Type
- 6.2.Mergers & Acquisitions, Partnerships, Product Launch, and Collaboration in Global Cardiac AI Monitoring and Diagnostics Market
7. Global Cardiac AI Monitoring and Diagnostics Market, By Product (USD Million) 2021-2034
- 7.1.Hardware
- 7.2.Software solutions
- 7.3.Services
8. Global Cardiac AI Monitoring and Diagnostics Market, By Type (USD Million) 2021-2034
- 8.1.Cardiac diagnostics
- 8.1.1.Imaging
- 8.1.2.ECG-based
- 8.1.3.Other diagnostic techniques
- 8.2.Cardiac monitoring
9. Global Cardiac AI Monitoring and Diagnostics Market, By Application (USD Million) 2021-2034
- 9.1.Cardiac arrhythmias
- 9.2.Stroke
- 9.3.Ischemic heart disease
- 9.4.Stenosis
- 9.5.Other applications
10. Global Cardiac AI Monitoring and Diagnostics Market, By End-User (USD Million) 2021-2034
- 10.1.Hospitals
- 10.2.Specialty clinics
- 10.3.Diagnostic centers
- 10.4.Research and academic institutes
- 10.5.Other end-users
11. Global Cardiac AI Monitoring and Diagnostics Market, (USD Million) 2021-2034
- 11.1. Global Cardiac AI Monitoring and Diagnostics Market Size and Market Share
12. Global Cardiac AI Monitoring and Diagnostics Market, By Region, (USD Million) 2021-2034
- 12.1.Asia-Pacific
- 12.1.1.Australia
- 12.1.2.China
- 12.1.3.India
- 12.1.4.Japan
- 12.1.5.South Korea
- 12.1.6.Rest of Asia-Pacific
- 12.2.Europe
- 12.2.1.France
- 12.2.2.Germany
- 12.2.3.Italy
- 12.2.4.Spain
- 12.2.5.United Kingdom
- 12.2.6.Rest of Europe
- 12.3.Middle East and Africa
- 12.3.1.Kingdom of Saudi Arabia
- 12.3.2.United Arab Emirates
- 12.3.3.Qatar
- 12.3.4.South Africa
- 12.3.5.Egypt
- 12.3.6.Morocco
- 12.3.7.Nigeria
- 12.3.8.Rest of Middle-East and Africa
- 12.4.North America
- 12.4.1.Canada
- 12.4.2.Mexico
- 12.4.3.United States
- 12.5.Latin America
- 12.5.1.Argentina
- 12.5.2.Brazil
- 12.5.3.Rest of Latin America
13. Company Profile
- 13.1. CardiAI
- 13.1.1. Company details
- 13.1.2.Financial outlook
- 13.1.3.Product summary
- 13.1.4.Recent developments
- 13.2. Cleerly, Inc
- 13.2.1.Company details
- 13.2.2.Financial outlook
- 13.2.3.Product summary
- 13.2.4.Recent developments
- 13.3. DiA Imaging Analysis
- 13.3.1.Company details
- 13.3.2.Financial outlook
- 13.3.3.Product summary
- 13.3.4.Recent developments
- 13.4. HeartVista Inc
- 13.4.1. Company details
- 13.4.2. Financial outlook
- 13.4.3. Product summary
- 13.4.4. Recent developments
- 13.5. IDOVEN
- 13.5.1. Company details
- 13.5.2. Financial outlook
- 13.5.3. Product summary
- 13.5.4. Recent developments
- 13.6. Koninklijke Philips N.V
- 13.6.1. Company details
- 13.6.2. Financial outlook
- 13.6.3. Product summary
- 13.6.4. Recent developments
- 13.7. RSIP Vision
- 13.7.1. Company details
- 13.7.2. Financial outlook
- 13.7.3. Product summary
- 13.7.4. Recent developments
- 13.8. Tempus
- 13.8.1.Company details
- 13.8.2.Financial outlook
- 13.8.3.Product summary
- 13.8.4.Recent developments
- 13.9.Ultrasight
- 13.9.1.Company details
- 13.9.2.Financial outlook
- 13.9.3.Product summary
- 13.9.4.Recent developments
- 13.10.Ultromics Limited
- 13.10.1.Company details
- 13.10.2.Financial outlook
- 13.10.3.Product summary
- 13.10.4.Recent developments
- 13.11.Others
14. Conclusion
15. List of Abbreviations
16. Reference Links
SPER Market Research’s methodology uses great emphasis on primary research to ensure that the market intelligence insights are up to date, reliable and accurate. Primary interviews are done with players involved in each phase of a supply chain to analyze the market forecasting. The secondary research method is used to help you fully understand how the future markets and the spending patterns look likes.
The report is based on in-depth qualitative and quantitative analysis of the Product Market. The quantitative analysis involves the application of various projection and sampling techniques. The qualitative analysis involves primary interviews, surveys, and vendor briefings. The data gathered as a result of these processes are validated through experts opinion. Our research methodology entails an ideal mixture of primary and secondary initiatives.
Frequently Asked Questions About This Report
Cardiac AI Monitoring and Diagnostics Market is projected to reach USD 13780.98 million by 2034, growing at a CAGR of of 27.11% during the forecast period.
Cardiac AI Monitoring and Diagnostics Market grew in Market size from 2025. The Market is expected to reach USD 13780.98 million by 2034, at a CAGR of 27.11% during the forecast period.
Cardiac AI Monitoring and Diagnostics Market CAGR of 27.11% during the forecast period.
You can get the sample pages by clicking the link - Click Here
Cardiac AI Monitoring and Diagnostics Market size is USD 13780.98 million from 2025 to 2034.
Cardiac AI Monitoring and Diagnostics Market is covered By Product, By Type, By Application, By End-User
By Product, By Type, By Application, By End-User
CardiAI, Cleerly, Inc, DiA Imaging Analysis, HeartVista Inc, IDOVEN, Koninklijke Philips N.V, RSIP Vision, Tempus, Ultrasight, Ultromics Limited.
The report includes an in-depth analysis of the Global Cardiac AI Monitoring and Diagnostics Market, including market size and trends, product mix, Applications, and supplier analysis.
PLACE AN ORDER
Year End Discount
Sample Report
Pre-Purchase Inquiry
NEED CUSTOMIZATION?
Request CustomizationCALL OR EMAIL US
100% Secure Payment
Related Reports
Have a glance of the Report
Our Global Clients
Our data-driven insights have influenced the strategy of 200+ reputed companies across the globe.
